Rhenman & Partners Asset Management AB
Position in GILD — Gilead Sciences, Inc.
CIK 1599882
Stockholm, V7
Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$22,520,105
-$859,212 QoQ
Shares Held
178,250
+6.3% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
2.13%
of 13F equity value
Holder Rank
#313
of 2,266 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rhenman & Partners Asset Management AB holds $173,015,372 across 8 Drug Manufacturers - General names. GILD ranks #5 (13.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
151,500 | $28,727,430 | |
| 2 | MRK |
Merck & Co., Inc.
|
213,500 | $27,434,750 | |
| 3 | LLY |
ELI LILLY & Co
|
22,315 | $26,765,282 | |
| 4 | ABBV |
AbbVie Inc.
|
96,775 | $24,352,461 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
178,250 | $22,520,105 | |
| 6 | BIIB |
Biogen Inc.
|
94,850 | $20,493,291 | |
| 7 | JNJ |
Johnson & Johnson
|
72,500 | $18,412,825 | |
| 8 | AMGN |
Amgen Inc
|
11,900 | $4,309,228 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,520,105 | 178,250 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $23,379,317 | 167,750 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $15,483,651 | 126,150 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,896,650 | 80,150 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $18,642,790 | 168,150 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $26,163,675 | 233,500 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $23,600,535 | 255,500 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $30,727,360 | 366,500 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $16,363,485 | 238,500 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $9,302,750 | 127,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $20,981,590 | 259,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $17,535,960 | 234,000 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $18,034,380 | 234,000 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $21,489,230 | 259,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $23,179,500 | 270,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $16,656,300 | 270,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,362,000 | 200,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $10,106,500 | 170,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $19,967,750 | 275,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $20,955,000 | 300,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $20,658,000 | 300,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $22,620,500 | 350,000 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $22,430,100 | 385,000 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $18,325,100 | 290,000 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $17,696,200 | 230,000 | Shares | Sole | 2020-07-16 | |
| No filing history on record for this holder in this stock. | ||||||